Levels of IL-1β and IL-1ra in cerebrospinal fluid of human patients after single and prolonged seizures

NeuroImmunoModulation

Volumn 17, Issue 1, 2009, Pages 19-22

  Lehtimäki, Kai A ^a   Keränen, Tapani ^a   Palmio, Johanna ^a   Peltola, Jukka ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cerebrospinal fluid; Cytokine; Neuronal plasticity; Seizure

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; BIOLOGICAL MARKER; NEUROTOXIN;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOCAL EPILEPSY; HUMAN; PRIORITY JOURNAL; TONIC CLONIC SEIZURE; CELL PROTECTION; CEREBROSPINAL FLUID; CHRONIC DISEASE; DOWN REGULATION; EPILEPSY; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; RECURRENT DISEASE; SEIZURE; UPREGULATION;

BIOLOGICAL MARKERS; CHRONIC DISEASE; CYTOPROTECTION; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPILEPSY; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; NEUROTOXINS; RECURRENCE; SEIZURES; UP-REGULATION;

EID: 70349836252     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000243081     Document Type: Article

References (23)

1. Kossmann T, Hans VH, Imhof HG, Stocker R, Grob P, Trentz O, Morganti-Kossmann C: Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock 1995; 4: 311-317.
2. Peltola J, Hurme M, Miettinen A, Keränen T: Elevated levels of interleukin-6 may occur in cerebrospinal fluid from patients with recent epileptic seizures. Epilepsy Res 1998; 31: 129-133.
3. Hans VH, Kossmann T, Lenzlinger PM, Probstmeier R, Imhof HG, Trentz O, Morganti-Kossmann MC: Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release into cerebrospinal fluid. J Cereb Blood Flow Metab 1999; 19: 184-194.
4. Vila N, Castillo J, Davalos A, Chamorro A: Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000; 31: 2325-2329.
5. Eriksson C, Van Dam AM, Lucassen PJ, Bol JG, Winblad B, Schultzberg M: Immunohistochemical localization of interleukin-1beta, interleukin-1 receptor antagonist and interleukin-1beta converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid. Neuroscience 1999; 93: 915-930.
6. Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F, De Simoni MG: Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 1999; 19: 5054-5065.
7. Panegyres PK, Hughes J: The neuroprotective effects of the recombinant interleukin-1 receptor antagonist rhIL-1ra after excitotoxic stimulation with kainic acid and its relationship to the amyloid precursor protein gene. J Neurol Sci 1998; 154: 123-132.
8. Penkowa M, Molinero A, Carrasco J, Hidalgo J: Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures. Neuroscience 2001; 102: 805-818.
9. Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A, De Simoni MG, Sperk G, Andell-Jonsson S, Lundkvist J, Iverfeldt K, Bartfai T: Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci USA 2000; 97: 11534-11539.
10. Kalueff AV, Lehtimäki KA, Ylinen A, Honkaniemi J, Peltola J: Intranasal administration of human IL-6 increases the severity of chemically induced seizures in rats. Neurosci Lett 2004; 365: 106-110.
11. Peltola J, Palmio J, Korhonen L, Suhonen Miettinen A, Hurme M, Lindholm D, Keränen T: Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res 2000; 41: 205-211.
12. Lehtimäki KA, Keränen T, Huhtala H, Hurme M, Ollikainen J, Honkaniemi J, Palmio J, Peltola J: Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration. J Neuroimmunol 2004; 152: 121-125.
13. Lehtimäki KA, Keränen T, Huuhka M, Palmio J, Hurme M, Leinonen E, Peltola J: Increase in plasma pro-inflammatory cytokines after electroconvulsive therapy in patients with depressive disorder. J ECT 2008; 24: 88-91.
14. Lehtimäki KA, Keränen T, Palmio J, Mäkinen R, Hurme M, Honkaniemi J, Peltola Increased plasma levels of cytokines after seizures in localization-related epilepsy. Acta Neurol Scand 2007; 116: 226-230.
15. Eriksson C, Zou LP, Ahlenius S, Winblad B, Schultzberg M: Inhibition of kainic acid induced expression of interleukin-1 beta and interleukin-1 receptor antagonist mRNA in the rat brain by NMDA receptor antagonists. Brain Res Mol Brain Res 2000; 85: 103-113.
16. Minami M, Kuraishi Y, Yamaguchi T, Nakai S, Hirai Y, Satoh M: Convulsants induce interleukin-1 beta messenger RNA in rat brain. Biochem Biophys Res Commun 1990; 171: 832-837.
17. Chapman S, Kadar T, Gilat E: Seizure duration following sarin exposure affects neuroinflammatory markers in the rat brain. Neurotoxicology 2006; 27: 277-283.
18. Eriksson C, Tehranian R, Iverfeldt K, Winblad B, Schultzberg M: Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration. J Neurosci Res 2000; 60: 266-279.
19. Lehtimäki KA, Peltola J, Koskikallio E, Keränen T, Honkaniemi J: Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures. Brain Res Mol Brain Res 2003; 110: 253-260.
20. Gruol DL, Nelson TE: Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997; 15: 307-339.
21. Vezzani A, Balosso S, Ravizza T: The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 2008; 22: 797-803.
22. Fukuda M, Suzuki Y, Ishizaki Y, Kira R, Kikuchi C, Watanabe S, Hino H, Morimoto T, Hara T, Ishii E: Interleukin-1β enhances susceptibility to hyperthermia-induced seizures in developing rats. Seizure 2009; 18: 211-214.
23. Rizzi M, Perego C, Aliprandi M, Richichi C, Ravizza T, Colella D, Veliskova J, Moshe SL, De Simoni MG, Vezzani A: Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol Dis 2003; 14: 494-503.